NDC 61703-343
Mitoxantrone
Mitoxantrone
Mitoxantrone is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Mitoxantrone Hy.
| Product ID | 61703-343_17c18d16-76a7-447d-bbcd-7ad7ca4b0787 |
| NDC | 61703-343 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mitoxantrone |
| Generic Name | Mitoxantrone |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2006-04-11 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA076871 |
| Labeler Name | Hospira, Inc. |
| Substance Name | MITOXANTRONE HY |
| Active Ingredient Strength | 2 mg/mL |
| Pharm Classes | Topoisomerase I |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |